Skip to main content
. 2023 Aug 29;24:682. doi: 10.1186/s12891-023-06789-w

Table 1.

Clinical data of the patient in Bruunstrom stage

Characteristics Total Bruunstrom Stage P
I II III IV V VI
Total 60(100%) 19(31.67%) 10(16.67%) 7(11.67%) 10(16.67%) 7(11.67%) 7(11.76%) /
Gendera 60(100%) > 0.05
 Male 39(65%) 7(17.9%) 8(20.5%) 6(15.4%) 7(17.9%) 7(17.9%) 4(10.3%)
 Female 21(35%) 12(57.1%) 2(9.5%) 1(4.8%) 3(14.3%) 0(0.0%) 3(14.3%)
Ageb 54.37 ± 14.85 54.16 ± 14.21 47.30 ± 15.08 43.43 ± 17.45 58.70 ± 8.49 60.71 ± 5.88 63.43 ± 19.40 > 0.05
BMIc

25.55

(24.04,29.16)

27.68

(24.41,30.08)

25.21

(23.49,29.69)

26.67

(23.66,32.65)

24.72

(24.03,26.22)

26.44

(24.49,53.48)

24.97

(19.90,27.64)

> 0.05
Involved Limbsa 60(100%) > 0.05
 Left 34(56.67%) 6(17.6%) 8(23.5%) 5(14.7%) 9(26.5%) 1(2.9%) 5(14.7%)
 Right Side 26(43.33%) 13(50.0%) 2(7.7%) 2(7.7%) 1(3.8%) 6(23.1%) 2(7.7%)
Clinical Diagnosisa 60(100%) > 0.05
 Encephalorrhagia 17(28.33%) 7(41.2%) 5(29.4%) 4(23.5%) 1(5.9%) 0(0.0%) 0(0.0%)
 Cerebral Infarction 43(71.67%) 12(27.9%) 5(11.6%) 3(7.0%) 9(20.9%) 7(16.3%) 7(16.3%)

Notes: Values are the number of patients. a, Variable reported as the number of patients (percentage). Chi-Square Test was used to compare the differences between the six groups; b, Variable reported as mean ± standard deviation. One-way ANOVA was used to analyze the comparison between the two groups; the significance level is 0.05; c, Variable reported as the median (inter-quartile range, IQR), Kruskal-Wallis test for comparison between six groups, the significance level is 0.05.